Every year, on 7 April 2026, the World Health Organization marks World Health Day under the theme “Together for Health. Stand with Science.” The message is clear, but its implications are far-reaching. In today’s health landscape, scientific progress no longer happens in isolation. It depends on how effectively knowledge, expertise, and stakeholders are connected.
Health challenges are becoming increasingly complex, spanning chronic diseases, emerging infections, advanced diagnostics, and data driven healthcare. Scientific excellence remains essential, but it is not enough on its own. What ultimately determines impact is the ability to translate research into solutions that reach patients, citizens, and healthcare systems.
For organisations and consortia working within Horizon Europe and beyond, this means recognising collaboration as a strategic tool. One that enables alignment, accelerates innovation, and increases the likelihood of real-world impact.
This is where collaboration becomes more than a principle. It becomes a structured approach to innovation.
Why “Together for Science” Matters in Europe
Europe’s strength in health research and innovation lies in its ability to bring together diverse actors across countries and disciplines. Addressing complex challenges requires coordinated contributions from:
- Academic researchers advancing scientific knowledge
- Small and medium sized enterprises and industry developing scalable solutions
- Clinicians ensuring relevance to patient care
- Policymakers creating enabling frameworks
- Patients and citizens contributing lived experience, societal perspective, and trust
Programmes such as Horizon Europe are designed to enable this collaboration at scale. However, collaboration alone does not guarantee impact. Without structure and alignment, even strong consortia can struggle to move from results to real world application.
At the Eurice Group, collaboration is not considered a secondary outcome. It is intentionally designed and managed as the foundation of innovation readiness.
Building Innovation Ecosystems, Not Just Projects
Health innovation evolves within ecosystems where stakeholders, knowledge, and resources interact continuously. These ecosystems require more than coordination. They require:
- Independent innovation management to ensure trust and neutrality
- Alignment of diverse stakeholder interests across sectors and countries
- Transparent governance that supports efficient decision making
- Bridging of Technology Readiness Levels from early research to deployment
- A clear focus on translating scientific results into societal and market impact
“Together for Science” becomes effective when collaboration is structured, professionally governed, and aligned with impact objectives. This is how research moves beyond discovery and becomes innovation that can be implemented.
Across our Health innovation ecosystem, collaboration takes many forms but always serves a common goal. Turning scientific excellence into tangible impact.
AI and Digital Health: METASTRA
In complex clinical settings, decision making often relies on incomplete or subjective information. The METASTRA project addresses this challenge by combining artificial intelligence with advanced biomechanical modelling to improve how clinicians assess fracture risk in cancer patients with spinal metastases.
Cancer affects 584 per 100,000 people in Europe each year, and several of the most common primary tumours, including breast, prostate, kidney, and lung cancer, metastasize to the vertebrae in 30 to 70% of cases. Due to the current non patient specific approach to fracture risk assessment, around 30% of these patients experience vertebral fractures, with approximately 90% requiring surgery.
METASTRA brings together clinicians, engineers, data scientists, and industry partners to develop a data driven decision support system that enables more precise and personalised care.
What makes METASTRA a strong example of “Together for Science” is the integration of multidisciplinary expertise into a clinically applicable solution. By aligning medical insight, computational modelling, and implementation pathways, the project moves beyond algorithm development towards real world decision support in oncology care.
Early Intervention and Precision Medicine: INTERCEPT
Chronic diseases are often diagnosed only after significant progression. The INTERCEPT project takes a fundamentally different approach by aiming to identify and intervene before Crohn’s disease develops.
By validating predictive biomarkers and developing a blood based risk score, INTERCEPT enables the identification of individuals at high risk years before symptoms appear. The project connects clinicians, academic researchers, industry partners, and patient organisations across Europe and beyond to translate these insights into clinical practice.
What makes INTERCEPT a powerful example of “Together for Science” is its integrated, cross sector approach. Large scale clinical validation combined with an innovative prevention trial connects discovery, data, and patient care within a single framework. This shifts the paradigm from treating disease to anticipating and preventing it.
Infectious Diseases and Pandemic Preparedness: NoVir
Emerging viral threats require solutions that can respond rapidly across different pathogens. The NoVir project addresses this need by developing a broad spectrum, messenger RNA based antiviral therapy designed to act against multiple viruses.
At its core is a first in class therapeutic that activates innate immune responses at virus entry sites, offering a mutation independent mechanism of action. The project combines preclinical research with clinical trials in both healthy individuals and high risk patient groups to evaluate its effectiveness across respiratory and systemic infections.
What makes NoVir a strong example of “Together for Science” is its integration of academic research, clinical validation, and industry driven development within a European framework. By aligning expertise across disciplines and sectors, the project moves beyond pathogen specific approaches towards a scalable solution for pandemic preparedness, strengthening Europe’s ability to respond to future health crises.
Talent Development: From Fellows to Leaders
Sustainable innovation depends on people, but also on how their careers evolve within collaborative ecosystems. Through initiatives such as circRTrain and other Marie Skłodowska Curie Doctoral Networks, early stage researchers are embedded in interdisciplinary and cross sector environments. These programmes connect academia, industry, and healthcare, equipping researchers with both scientific and innovation oriented skills.
As highlighted in EURICE’s recent article From Fellows to Leaders, doctoral candidates do not only contribute during a project’s lifetime. They continue to shape the ecosystem beyond it. Researchers who started as fellows in collaborative networks go on to become principal investigators, supervisors, and innovation leaders in new European initiatives.
This demonstrates that “Together for Science” is not only about connecting expertise today. It is about developing the people who will drive innovation tomorrow.
As health challenges continue to evolve, the ability to connect science will become even more critical. Europe’s leadership in health innovation will depend on how effectively it can integrate expertise, align stakeholders, and translate knowledge into action.
Connecting science is what turns potential into impact. Together for health means standing with science.